Immunocore Holdings (IMCR)

Immunocore Holdings (IMCR) Stock Price & Analysis


IMCR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$42.21 - $67.43
Previous Close$52.58
Average Volume (3M)301.86K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)£332.54M
Total Debt (Recent Filing)£69.30M
Price to Earnings (P/E)-18.5
Feb 29, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.85
Shares Outstanding48,088,346
10 Day Avg. Volume374,642
30 Day Avg. Volume301,863
Standard Deviation0.15
Financial Highlights & Ratios
Price to Book (P/B)8.07
Price to Sales (P/S)17.77
Price to Cash Flow (P/CF)N/A
P/FCF Ratio404.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside51.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10



Ownership Overview

14.33% Mutual Funds
44.57% Other Institutional Investors
41.10% Public Companies and
Individual Investors


What was Immunocore Holdings’s price range in the past 12 months?
Immunocore Holdings lowest stock price was $42.21 and its highest was $67.43 in the past 12 months.
    What is Immunocore Holdings’s market cap?
    Currently, no data Available
    When is Immunocore Holdings’s upcoming earnings report date?
    Immunocore Holdings’s upcoming earnings report date is Feb 29, 2024 which is in 84 days.
      How were Immunocore Holdings’s earnings last quarter?
      Immunocore Holdings released its earnings results on Nov 07, 2023. The company reported $0.051 earnings per share for the quarter, beating the consensus estimate of -$0.363 by $0.414.
        Is Immunocore Holdings overvalued?
        According to Wall Street analysts Immunocore Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Immunocore Holdings pay dividends?
          Immunocore Holdings does not currently pay dividends.
          What is Immunocore Holdings’s EPS estimate?
          Immunocore Holdings’s EPS estimate is -$0.26.
            How many shares outstanding does Immunocore Holdings have?
            Immunocore Holdings has 48,088,345 shares outstanding.
              What happened to Immunocore Holdings’s price movement after its last earnings report?
              Immunocore Holdings reported an EPS of $0.051 in its last earnings report, beating expectations of -$0.363. Following the earnings report the stock price went up 5.712%.
                Which hedge fund is a major shareholder of Immunocore Holdings?
                Among the largest hedge funds holding Immunocore Holdings’s share is Baker Bros Advisors LP. It holds Immunocore Holdings’s shares valued at 131M.


                  Company Description

                  Immunocore Holdings

                  Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases.


                  Top 5 ETFs holding IMCR

                  Market Value
                  Smart Score
                  Fidelity Nasdaq Composite Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold IMCR. The ETFs are listed according to market value of IMCR within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Apellis Pharmaceuticals
                  Adaptimmune Therapeutics
                  Kura Oncology
                  Crispr Therapeutics AG

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis